15. Factors associated with door-to-needle time in acute ischemic stroke patients received thrombolysis

Ho Sy Duong, Dang Trung Anh, Nguyen Ngoc Hoa, Hoang Bui Hai

Main Article Content

Abstract

The study aimed to describe the door-to-needle time, the time from hospital arrival to intravenous thrombolysis administration in patients with acute ischemic stroke and several factors associated with this time. This was a retrospective observational study conducted at Nghe An Friendship General Hospital on 219 patients with acute ischemic stroke receiving the thrombolytic treatment. The data analysis involved dividing the study population into two groups: those with door-to-needle time below 60 minutes and those with door-to-needle time greater than 60 minutes. The results showed that during the study period, the proportion of patients with door-to-needle time below 60 minutes was 69.4%. Factors including longer onset-to-door time and shorter door-to-examination time were independent factors related to door-to-needle time below 60 minutes.

Article Details

References

1. Hacke WJL. ATLANTIS Trials Investigators: ECASS Trials Investigators; NINDS rt-PA Study Group Investigators: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768-774.
2. Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46-e99.
3. Fonarow GC, Smith EE, Saver JL, et al. Improving Door-to-Needle Times in Acute Ischemic Stroke: the design and rationale for the American Heart Association/American Stroke Association’s Target: Stroke initiative. Stroke. 2011;42(10):2983-2989.
4. Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064-2089.
5. Ton MD, Dao PV, Nguyen DT, et al. Sex disparity in stroke outcomes in a multicenter prospective stroke registry in Vietnam. Int J Stroke. 2023;18(9):1102-1111.
6. Meretoja A, Weir L Fau, Ugalde M, et al. Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months. Neurology. 2013;81(12):1071-6. doi: 10.1212/WNL.0b013e3182a4a4d2
7. Strbian D, Michel P, Ringleb P, et al. Relationship Between Onset-to-Door Time and Door-to-Thrombolysis Time. Stroke. 2013;44(10):2808-2813.
8. Huang Q, Ma Q-f, Feng J, et al. Factors Associated with In-Hospital Delay in Intravenous Thrombolysis for Acute Ischemic Stroke: Lessons from China. PLOS ONE. 2015;10(11):e0143145.
9. Kuhrij LS, Marang-van de Mheen PJ, van den Berg-Vos RM, et al. Determinants of extended door-to-needle time in acute ischemic stroke and its influence on in-hospital mortality: results of a nationwide Dutch clinical audit. BMC Neurol. 2019;19(1):265-265.
10. Van Schaik SM, Scott S, de Lau LML, et al. Short Door-to-Needle Times in Acute Ischemic Stroke and Prospective Identification of Its Delaying Factors. Cerebrovasc Dis Extra. 2015;5(2):75-83.
11. Tran D, Zhu Z, Shafie M, et al. Three easily-implementable changes reduce median door-to-needle time for intravenous thrombolysis by 23 minutes. BMC Neurol. 2019;19(1):300-300.